SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseasyJet Regulatory News (EZJ)

Share Price Information for easyJet (EZJ)

Share Price is delayed by 15 minutes
Get Live Data
500.00    0.00 (0.00%)
Bid:
499.50
Ask:
500.20
Spread: 0.70 (0.14%)
Market Cap: £3.74b
EZJ Live PriceLast checked at - London Stock Exchange

Intraday easyJet Share Chart

Amendment - Form 8.3 EASYJET PLC

Today 11:00

RNS Number : 3122I
Turiya Advisors Asia Limited
15 June 2026
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

Amendment - this form replaces RNS 1581I, published at 11:56 on 12/06/26. Changes have been made to Sections 1 and 2.

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Turiya Advisors Asia Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Easyjet Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 Jun 2026 (in addition the discloser has dealt on previous dates during the offer period as attached at the end of this form)

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

Β 

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

27 2/7p ordinary

Β 

Β 

Interests

Short positions

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Cash-settled derivatives:

Β 

16,255,212

2.14%

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

Β 

TOTAL:

16,255,212

2.14%

0

0

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

Β 

Β 

Β 

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

27 2/7p ordinary

SWAP

Β 

Increasing a long position

626,437

GBP4.7246

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

15 Jun 2026

Contact name:

Angela Tordesillas

Telephone number*:

+852 6468 5347

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

ATTACHMENT: ADDITIONAL DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Β 

Β 

Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Date

27 2/7p ordinary

SWAP

Opening a long position

6,676,084

GBP4.3426

01 June 2026

27 2/7p ordinary

SWAP

Increasing a long position

2,399,853

GBP4.5260

02 June 2026

27 2/7p ordinary

SWAP

Increasing a long position

1,509,669

GBP4.5213

03 June 2026

27 2/7p ordinary

SWAP

Increasing a long position

1,761,332

GBP4.6559

04 June 2026

27 2/7p ordinary

SWAP

Increasing a long position

1,460,973

GBP4.6575

05 June 2026

27 2/7p ordinary

SWAP

Increasing a long position

1,432,310

GBP4.6821

08 June 2026

27 2/7p ordinary

SWAP

Increasing a long position

388,554

GBP4.6984

09 June 2026

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETAKPBDCBKKQAD
Date   Source Headline
20th Jun 20225:30 pmEQSHolding(s) in Company
20th Jun 20227:00 amEQSSummer 2022 Trading Update
20th Jun 20227:00 amEQSSummer 2022 Trading Update
13th Jun 20224:30 pmEQSDirector/PDMR Shareholding
13th Jun 20224:30 pmEQSDirector/PDMR Shareholding
9th Jun 20222:30 pmEQSHolding(s) in Company
9th Jun 20222:30 pmEQSHolding(s) in Company
23rd May 202210:00 amEQSDirector/PDMR Shareholding
19th May 20227:03 amRNSAppointment of Joint Corporate Broker
19th May 20227:00 amRNSHalf-year Report
11th May 20223:00 pmEQSDirector/PDMR Shareholding
12th Apr 20221:15 pmEQSDSH-Director/PDMR Shareholding*
12th Apr 20227:00 amEQSTrading statement for the six months ended 31 March 2022
31st Mar 202210:45 amEQSDirector/PDMR Shareholding
28th Mar 20223:03 pmRNSDirector Declaration
11th Mar 202211:43 amRNSDirector/PDMR Shareholding
8th Mar 20221:38 pmRNSDirector/PDMR Shareholding
7th Mar 20222:46 pmRNSDirector/PDMR Shareholding
4th Mar 20224:49 pmRNSDirector/PDMR Shareholding
22nd Feb 20222:31 pmRNSDirector/PDMR Shareholding
17th Feb 20228:30 amRNSDirector/PDMR Shareholding
14th Feb 20229:15 amRNSPublication of Prospectus
11th Feb 202211:26 amRNSDirector/PDMR Shareholding
10th Feb 20224:00 pmRNSResult of AGM
27th Jan 20227:00 amRNSQ1 Trading Statement
21st Jan 20229:00 amRNSUpdate on Annual General Meeting Arrangements
13th Jan 20221:26 pmRNSHolding(s) in Company
12th Jan 20226:02 pmRNSHolding(s) in Company
12th Jan 202212:48 pmRNSHolding(s) in Company
11th Jan 20221:58 pmRNSDirector/PDMR Shareholding
10th Jan 202210:01 amRNSNotice of AGM
5th Jan 20225:30 pmRNSHolding(s) in Company
4th Jan 20227:00 amRNSHolding(s) in Company
30th Dec 20214:38 pmRNSHolding(s) in Company
17th Dec 20215:00 pmRNSHolding(s) in Company
17th Dec 202110:06 amRNSDirector Declaration
16th Dec 20212:22 pmRNSHolding(s) in Company
16th Dec 20219:45 amRNSDirector/PDMR Shareholding
15th Dec 20215:33 pmRNSHolding(s) in Company
13th Dec 20211:13 pmRNSDirector/PDMR Shareholding
10th Dec 20214:44 pmRNSHolding(s) in Company
10th Dec 202110:01 amRNSAnnual Report and Accounts
8th Dec 20215:29 pmRNSHolding(s) in Company
6th Dec 20217:30 amRNSJohn Barton
2nd Dec 20216:05 pmRNSHolding(s) in Company
1st Dec 20215:35 pmRNSDirector/PDMR Shareholding
1st Dec 20214:56 pmRNSHolding(s) in Company
30th Nov 20216:30 pmRNSHolding(s) in Company
30th Nov 202111:45 amRNSHolding(s) in Company
30th Nov 20217:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.